| Literature DB >> 24093170 |
César Serrano1, Suzanne George.
Abstract
This article presents an overview of the current literature about the biology, pathology, and the clinical management of leiomyosarcoma. In addition, the article emphasizes and discusses the current systemic treatment options available for patients with leiomyosarcoma, which range from cytotoxic chemotherapy to target therapies. Particular leiomyosarcoma subtypes, such as uterine leiomyosarcoma and inferior vena cava leiomyosarcoma, are discussed separately.Entities:
Keywords: Chemotherapy; Leiomyosarcoma; Prognostic factors; Targeted therapy; Uterine leiomyosarcoma
Mesh:
Year: 2013 PMID: 24093170 DOI: 10.1016/j.hoc.2013.07.002
Source DB: PubMed Journal: Hematol Oncol Clin North Am ISSN: 0889-8588 Impact factor: 3.722